NewswireToday - /newswire/ -
Santa Monica, CA, United States, 2007/09/06 - Plexus Ventures is pleased to announce its appointment by GlaxoSmithKline Consumer Healthcare to augment the company's internal resources by providing additional business development services.
Bob Moran, President of Plexus Ventures, commented: "With 10 seasoned business development professionals in eight cities worldwide, Plexus Ventures is well-positioned to help GSK achieve its growth objectives."
About Plexus Ventures
Plexus Ventures (plexusventures.com), founded in 1990, provides strategic advice, business development and alliance management services to clients in the pharmaceutical, biotechnology and drug delivery industries worldwide. Plexus Ventures assists its clients in the areas of in-licensing, out-licensing, acquisitions, divestitures and strategic partnerships. With offices in Frankfurt, Indianapolis, London, Los Angeles, Milan, Philadelphia, Tokyo and Warsaw, Plexus Ventures possesses the capabilities to effectively serve clients in the United States, Europe and Asia. Plexus Ventures is both well-known and well respected by leading research-based pharmaceutical companies worldwide.
GlaxoSmithKline (gsk.com) is one of the world's leading research-based pharmaceutical and healthcare companies - is committed to improving the quality of human life by enabling people to do more, feel better and live longer.
About GlaxoSmithKline Consumer Healthcare
GlaxoSmithKline Consumer Healthcare is one of the world's largest over-the-counter consumer healthcare products companies. Its more than 30 well-known brands include the leading smoking cessation products, Nicoderm CQ® and Commit® (known as Niquitin® in Europe and International markets); Alli™, the new product in the US for weight loss, many medicine cabinet staples including Panadol®, Abreva®, Aquafresh®, Sensodyne® and Tums®; and nutritional healthcare products such as Lucozade®, Horlicks® and Ribena®.